These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1576341)
1. Diagnosis of colorectal and ovarian carcinoma. Application of immunoscintigraphic technology. Targeted Diagn Ther; 1992; 6():1-237. PubMed ID: 1576341 [No Abstract] [Full Text] [Related]
2. Radioimmunodetection in cancer identification. Goldenberg DM; Larson SM J Nucl Med; 1992 May; 33(5):803-14. PubMed ID: 1569493 [No Abstract] [Full Text] [Related]
3. Oncoscint for detection of disseminated colorectal and ovarian cancer. Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207 [No Abstract] [Full Text] [Related]
6. Radioimmunoscintigraphy in the management of colorectal and ovarian cancer: does identification improve outcome? Markman M Cancer Invest; 2000; 18(3):289-90. PubMed ID: 10755000 [No Abstract] [Full Text] [Related]
7. Cancer patients benefit from monoclonal imaging. Neal CE Diagn Imaging (San Franc); 1993 Jun; 15(6):92-7. PubMed ID: 10148791 [No Abstract] [Full Text] [Related]
8. [Methodology and clinical usefulness of radioimmunoimaging using radiolabeled monoclonal antibodies]. Endo K; Watanabe N Nihon Rinsho; 1996 Jun; 54(6):1604-9. PubMed ID: 8691616 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis. Neal CE; Johnson DL; Cornwell VL; Markwell S Clin Nucl Med; 1996 Aug; 21(8):638-42. PubMed ID: 8853918 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody imaging of colorectal and ovarian cancer. Haseman MK West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555 [No Abstract] [Full Text] [Related]
11. [Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases]. Baum RP; Hertel A; Hör G Immun Infekt; 1989 Feb; 17(1):22-4. PubMed ID: 2647623 [TBL] [Abstract][Full Text] [Related]
12. Application of radioimmunodetection with a radiolabeled monoclonal antibody to CEA (BW 431/26) in colorectal and breast cancer. Lind P Pathol Biol (Paris); 1993 Jan; 41(1):39. PubMed ID: 8316463 [No Abstract] [Full Text] [Related]
13. Imaging of colorectal carcinoma with 131I B72.3 monoclonal antibody. Carrasquillo JA Targeted Diagn Ther; 1992; 6():45-55. PubMed ID: 1576349 [No Abstract] [Full Text] [Related]
14. Immunoscintigraphy of colorectal carcinoma and the Loch Ness monster. Delaloye AB J Nucl Med; 1992 Oct; 33(10):1756-7. PubMed ID: 1403141 [No Abstract] [Full Text] [Related]
15. Image of the month-quiz case. Diagnosis: primary colorectal carcinoma with ovarian metastasis. Yi JA; Burlew CC; Barnett CC; Moore EE Arch Surg; 2012 Sep; 147(9):885-6. PubMed ID: 22987189 [No Abstract] [Full Text] [Related]
16. [Radioimmunoscintigraphy in the diagnosis of early and recurrent ovarian cancers]. Huang W; Cao ZY Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):174-6. PubMed ID: 8354097 [No Abstract] [Full Text] [Related]
17. Monoclonal antibody imaging in colon cancer: a transition from basic science to clinical application. Kim SL; Goldschmid S Am J Gastroenterol; 1994 Oct; 89(10):1910-2. PubMed ID: 7942701 [No Abstract] [Full Text] [Related]
18. Influence of MAb (F(Ab)2 OC 125 on the survival rate of ovarian carcinoma patients. Nesselhut T Hybridoma; 1993 Oct; 12(5):567-70. PubMed ID: 8300131 [No Abstract] [Full Text] [Related]
19. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer. Doerr RJ; Abdel-Nabi HH Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352 [No Abstract] [Full Text] [Related]
20. Challenges in immunoscintigraphy of ovarian cancer. Kim EE; Kasi LP Gynecol Oncol; 1993 Mar; 48(3):283-4. PubMed ID: 8462895 [No Abstract] [Full Text] [Related] [Next] [New Search]